Vanderbilt University Medical Center Selects Latent to Support Medication Access

Nashville, TN and San Francisco, CA— September 22, 2025 — Vanderbilt University Medical
Center (VUMC) has selected Latent, an AI-enabled medication access platform, to support
specialty and infusion prior authorization workflows. The effort is designed to streamline
administrative processes and create efficiencies in pharmacy operations.
‍
Latent’s platform uses large language models to analyze the patient chart and surface the
clinical information required for prior authorization, reducing review and submission cycles from
hours to minutes. The system is designed to improve first-pass approvals and shorten time to
therapy. It integrates with Epic and related operational tools to support clinic, pharmacy, and
infusion teams.
‍
“This initiative reflects our vision for medication access technology—fast, reliable, and deeply
integrated in the health system environment,” said Sri Somasundaram, Co-Founder of Latent.
“By reducing administrative bottlenecks in specialty and infusion, we can enable staff to focus
more on patient care and extend support to adherence and the broader care journey.”

About Latent
Latent is a health technology company focused on streamlining medication access. Its platform
uses clinical AI to support prior authorizations, 340B compliance, and appeals. By optimizing
pharmacy workflows and enabling centralization, Latent aims to accelerate time-to-therapy,
support scalable pharmacy expansion, and reduce administrative burden on staff. Learn more at
www.latenthealth.com.